Abstract
Purpose: In the U.S., adolescents and young adults (AYA) account for over 20% of all new HIV infections. Young men who have sex with men (YMSM), and particularly YMSM of color, are disproportionately impacted. In 2014, MSM accounted for 83% (29,418) of the estimated new HIV diagnoses among males aged 13 and older. Pre-exposure Prophylaxis (PrEP), an FDA-approved medication regimen, provides a 92–99% reduction in HIV risk. Current research indicates awareness and utilization of PrEP is low among primary care providers. This study aimed to improve access and utilization of PrEP for AYA within a large academic AYA medical practice through an educational intervention and implementation of an evidence-based guideline (EBG).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
